Anti-Smith Antibody Positive: معنى الذئبة والخطوات التالية

الفئات
المقالات
الصحة المناعية الذاتية تفسير نتائج التحاليل تحديث 2026 مناسب للمرضى

Anti-Sm is one of the most lupus-specific antibodies, but a laboratory result never replaces a clinical diagnosis. The useful question is whether the result fits your symptoms and the rest of your testing.

📖 ~11 دقيقة 📅
📝 نُشر: 🩺 تمت المراجعة طبيًا بواسطة: ✅ مبني على الأدلة
⚡ ملخص سريع v1.0 —
  1. الخصوصية of a confirmed anti-Sm result is usually about 95–99% for systemic lupus erythematosus.
  2. حساسية is low: only about 5–30% of people with lupus have anti-Sm antibodies.
  3. ANA threshold of at least 1:80 on HEp-2 cells is the EULAR/ACR classification entry criterion.
  4. Six points are assigned to anti-Sm antibodies in the 2019 EULAR/ACR lupus classification criteria.
  5. No universal titre defines severity because anti-Sm assays use different antigens and reporting units.
  6. فحوصات الكلى include urinalysis, urine protein-to-creatinine ratio, creatinine/eGFR, C3, C4, CBC, and anti-dsDNA.
  7. أعراض عاجلة include chest pain with breathlessness, seizure, confusion, visible blood in urine, or rapidly reduced urine output.

What a Positive Anti-Sm Result Actually Means

أن anti-Smith antibody positive result means your immune system has formed antibodies against Sm nuclear proteins. A confirmed result is highly specific for systemic lupus erythematosus, often 95–99%, but it does not diagnose lupus by itself; symptoms, examination findings, urine testing, blood counts, complement, and other antibodies determine whether lupus is the best explanation.

Anti-Smith antibody positive result shown as antibodies binding a nuclear Sm protein complex
الشكل 1: Antibodies binding nuclear Sm protein targets in an educational model.

I use anti-Sm as a diagnostic signpost, not a verdict. A patient with inflammatory joint swelling, rash, low C3, and protein in urine has a very different likelihood of lupus than a person with fatigue alone and one low-positive antibody. The نتائج ANA explains the usual starting point.

The name Smith came from an early patient, not a gene or family condition. Anti-Sm targets spliceosome proteins that process RNA inside cells; it does not directly measure current disease activity. That distinction matters when people assume a stronger-looking laboratory flag means more severe lupus.

As of September 28, 2026, an isolated anti-Sm result calls for careful review, not immediate treatment. In my clinical experience, a quiet urine abnormality can matter far more than the antibody number itself. الدكتور توماس كلاين has also seen confirmed anti-Sm positivity in people who never developed classifiable SLE.

Why Anti-Sm Is Specific but Not Sensitive for Lupus

Anti-Sm antibodies are highly specific but poorly sensitive for lupus. Roughly 5–30% of people with established SLE test positive, depending on ancestry, cohort selection, and assay, which means a negative anti-Sm result cannot rule lupus out.

Smith antibody lupus target represented by an anatomically accurate molecular spliceosome complex
الشكل 2: The Sm complex is a nuclear autoantibody target in lupus.

Specificity asks how rarely a test is positive without disease; sensitivity asks how often it detects disease when present. Anti-Sm performs very well on specificity and modestly on sensitivity. This is why the same antibody can be a persuasive clue when present yet unhelpful when absent.

Reported prevalence differs across populations. Some Black, Asian, and Hispanic lupus cohorts show higher anti-Sm prevalence than White European cohorts, although referral patterns and laboratory methods contribute. A group percentage cannot predict an individual's future kidney, skin, or joint involvement.

The 2019 EULAR/ACR criteria award anti-Sm antibodies 6 points, reflecting their discriminatory value, but antibodies alone do not establish classification (Aringer et al., 2019). Anti-dsDNA results may provide a more useful activity trend in some patients, particularly when renal disease is being assessed.

How an Anti-Sm Antibody Test Is Measured

Anti-Sm results have no universal normal range or severity titre. Laboratories use ELISA, multiplex bead assays, line immunoassays, or immunoprecipitation, and each method has its own negative, equivocal, and positive cutoffs.

Anti-Sm antibody test reagents in a multiplex laboratory assay with labelled sample wells
الشكل 3: Different anti-Sm assay methods use different numerical reporting scales.

One laboratory may report an index, another arbitrary units such as U/mL, and another only positive or negative. A value of 25 U/mL at one laboratory is not interchangeable with 25 U/mL elsewhere. The laboratory name, reference interval, and assay method belong in any specialist referral.

Low positives deserve scrutiny if the ANA is negative or the clinical picture is incompatible with lupus. Non-specific binding and assay discordance are uncommon but genuine issues, especially in broad automated panels. Read more about الاختبارات النوعية والكمية before comparing results across reports.

كانتيستي هو محلل اختبار الدم بالذكاء الاصطناعي that reads the reporting laboratory, date, companion markers, and result language rather than treating one flag as a diagnosis. An unexpected anti-Sm result is best viewed as a reason for clinician-led confirmation and context review.

How Anti-Sm Fits the Lupus Classification Criteria

Anti-Sm contributes 6 points in the 2019 EULAR/ACR SLE classification criteria, but 10 points and at least one clinical criterion are required. An ANA of at least 1:80 on HEp-2 cells is the entry criterion before any points are counted.

Lupus assessment pathway showing ANA screening, anti-Sm testing, and clinical organ review
الشكل 4: Lupus assessment combines antibody results with clinical organ findings.

Classification criteria make research cohorts consistent; they do not replace a physician's diagnostic judgment. A patient may have lupus before meeting every classification feature, or may meet a numerical threshold while another illness better explains the presentation. This nuance prevents both delayed care and overdiagnosis.

Anti-Sm sits in the SLE-specific antibody domain with anti-dsDNA; only the highest item within a domain counts. Kidney biopsy class III or IV lupus nephritis scores 10 points, while fever scores 2 and acute cutaneous lupus scores 6. The numbers describe a framework, not a disease meter.

The earlier SLICC system also required immunologic and clinical evidence, reinforcing the same core principle: laboratory autoimmunity needs clinical correlation (Petri et al., 2012). Our C3، C4 و ANA ترشدنا shows the tests commonly read alongside anti-Sm.

Symptoms That Make an Anti-Sm Result More Meaningful

Anti-Sm is more clinically meaningful when it accompanies objective lupus features. These include inflammatory arthritis, photosensitive or acute rashes, mouth ulcers, serositis, cytopenias, neurologic features, proteinuria, or active urinary sediment.

Clinical lupus review with a patient hand indicating joint stiffness beside laboratory report materials
الشكل 5: Symptoms and physical findings determine whether an antibody result fits lupus.

Inflammatory arthritis generally causes swollen or tender joints with morning stiffness lasting 30–60 minutes or longer, rather than pain only after a busy day. Lupus rashes commonly spare the nasolabial folds, but skin findings are variable enough that photographs and dermatology review can be genuinely useful.

A history of recurrent painless mouth ulcers, sunlight-triggered rash, pleuritic chest pain, unexplained low white cells, and Raynaud-type color changes raises the pre-test probability. No single symptom is unique to SLE. Fibromyalgia, viral illness, thyroid disease, medication effects, and other autoimmune conditions can overlap.

Document patterns rather than trying to self-score lupus. A dated symptom diary, photographs of transient rash, medication list, and prior results help a rheumatologist substantially. People with cold-sensitive color changes may find our Raynaud blood-test overview useful while awaiting review.

Why Urine and Kidney Tests Matter After Anti-Sm Positivity

Urinalysis and urine protein measurement are essential after a concerning lupus antibody result because kidney inflammation can be silent. Persistent proteinuria of 500 mg per 24 hours, or a urine protein-to-creatinine ratio of 500 mg/g or higher, warrants prompt specialist assessment in suspected SLE.

Lupus kidney screening represented by urine analysis chamber and renal filtration model
الشكل 6: Urine protein and sediment testing can reveal silent lupus kidney involvement.

A normal creatinine does not fully exclude early lupus nephritis. Creatinine rises late in some people because kidney reserve is substantial, while urine protein, red-cell casts, dysmorphic red cells, or declining complement may appear earlier. First-morning urine reduces dilution variability when a ratio is being checked.

Protein can arise from fever, strenuous exercise, diabetes, urinary infection, or contamination, so persistence matters. I usually want a repeat clean-catch urine sample and microscopy when a dipstick is positive. The practical details in our urine sediment guide can help readers understand the report.

New ankle swelling, foamy urine that persists, high blood pressure, or reduced urine should not wait for a routine annual review. Kidney involvement may require immunosuppressive treatment, but treatment choice depends on biopsy class, pregnancy plans, infection risk, and kidney function—not anti-Sm status alone.

The Companion Results Rheumatologists Check

The most useful companion tests are CBC with differential, creatinine/eGFR, urinalysis, urine protein ratio, C3, C4, anti-dsDNA, ESR, and CRP. Low C3 or C4 can support immune-complex activity, but normal complement does not exclude lupus.

Complement C3 and C4 laboratory assessment arranged beside a complete blood count sample analysis
الشكل 7: Complement, CBC, kidney, and urine results provide lupus context.

Complement reference intervals vary, but many laboratories list C3 around 90–180 mg/dL and C4 around 10–40 mg/dL. A low result is more persuasive when it is newly reduced from that person's own baseline and coincides with proteinuria or rising anti-dsDNA. Low complement results need pattern-based interpretation.

CBC changes may include leukopenia below 4.0 × 10⁹/L, lymphopenia below 1.0 × 10⁹/L, thrombocytopenia below 100 × 10⁹/L, or hemolytic anemia. A single borderline count after a viral illness is not equivalent to persistent immune cytopenia. Timing and repeat samples matter.

CRP is often normal or only modestly raised during uncomplicated lupus activity, whereas a markedly high CRP should widen the search for infection, serositis, or another inflammatory process. That is a clinical rule of thumb, not an absolute rule; WBC and CRP patterns can be especially helpful.

Does Anti-Sm Predict Severe Lupus or a Flare?

Anti-Sm positivity does not reliably measure lupus severity, flare intensity, or treatment response. It often persists for years, so clinicians do not usually repeat it to decide whether inflammation is improving.

Stable anti-Sm antibody pattern contrasted with changing lupus activity markers in an educational molecular display
الشكل 8: Anti-Sm usually remains stable while other lupus activity markers can change.

Some observational studies link anti-Sm with particular manifestations, including renal or neurologic disease in selected populations, but the associations are inconsistent after accounting for ancestry and coexisting antibodies. I would never forecast an individual's organ risk from anti-Sm alone. That approach creates anxiety without improving decisions.

For established lupus, trends in symptoms, examination, blood pressure, urine protein, urine sediment, creatinine, C3, C4, and anti-dsDNA are usually more actionable. A urine protein ratio that rises from 150 to 900 mg/g tells a more urgent story than a stable anti-Sm result.

Dr. Thomas Klein advises patients to ask which result will actually change the treatment plan. If the answer is anti-Sm alone, that deserves a conversation. A سجل زمني لاختبارات الدم can help separate biological change from a single noisy measurement.

Can Anti-Sm Be Positive Without Lupus?

Anti-Sm positivity outside lupus is unusual but possible, especially with low-level assay signals or discordant testing. A result that conflicts with a negative ANA, absent clinical features, or a different laboratory method should be reviewed before a lifelong diagnosis is considered.

Discordant antibody assay comparison using two different laboratory testing methods for anti-Sm
الشكل 9: Confirmatory testing helps resolve unexpected or low-level anti-Sm results.

Technical differences are the commonest reason two reports disagree. Solid-phase assays may detect limited protein fragments, while other methods identify different epitopes or use different thresholds. Repeating the identical panel without a clinical question can add confusion; a rheumatologist may instead request a methodologically different confirmation.

Other systemic autoimmune diseases can occasionally produce broad autoantibody reactivity, but true isolated anti-Sm positivity remains far more associated with SLE than most antibodies on an ENA panel. A positive test does not explain every symptom: thyroid disease, anemia, sleep disorders, and medication effects still deserve ordinary medical care.

Do not stop or start medication solely because of an antibody portal result. The broader principles in our positive antibody guide apply here: confirm identity, establish clinical fit, then decide whether monitoring is needed.

When to Repeat or Confirm an Anti-Sm Test

Repeat anti-Sm testing is most useful when the original result is low-positive, unexpected, or technically discordant. Repeating a stable, clearly positive anti-Sm result every 3–6 months rarely adds useful information in established lupus.

Repeat anti-Sm antibody testing workflow with paired laboratory sample dates and controlled assay preparation
الشكل 10: Repeat testing is most valuable when the original result conflicts with clinical findings.

Confirmation is reasonable when ANA is negative, symptoms are absent, the sample was tested as part of a large screen, or the report uses an equivocal category. Ask whether the laboratory can perform an ENA confirmation or whether a reference laboratory uses a different platform. Keep the original report; the assay name is useful data.

If symptoms are evolving, the repeat tests that usually matter more are urinalysis, urine protein ratio, CBC, creatinine, C3, C4, and anti-dsDNA. The right interval depends on findings: a patient with new proteinuria needs faster review than one with a normal examination and stable tests.

كانتيستي هو منصة تفسير تحليل الدم ديال AI that can place serial laboratory reports side by side and flag meaningful context changes for discussion with a clinician. It cannot diagnose lupus, but organized trends can prevent an old antibody result from overshadowing newer kidney or blood-count changes.

Medicines, Pregnancy, and Anti-Sm Antibodies

Anti-Sm antibodies do not cause drug-induced lupus and are not the main antibody used to estimate pregnancy-specific neonatal lupus risk. Anti-Ro/SSA and anti-La/SSB, rather than anti-Sm, guide fetal heart-block surveillance discussions.

Pregnancy planning consultation showing lupus antibody testing materials and fetal monitoring model without identifiable faces
الشكل 11: Pregnancy planning in lupus uses a broader antibody and medication review.

Classic drug-induced lupus more often involves antihistone antibodies and usually has less kidney or central nervous system involvement than idiopathic SLE. Hydralazine, procainamide, isoniazid, minocycline, and some biologic therapies are among medicines clinicians review when symptoms emerge. Never discontinue a prescribed medicine without a prescriber.

Pregnancy is safest when lupus has been clinically quiet for at least 6 months before conception, particularly after nephritis. Anti-Sm positivity itself does not determine delivery timing, anticoagulation, or treatment. Blood pressure, urine protein, kidney function, anti-Ro/La, and antiphospholipid antibodies are usually more decision-relevant.

People planning pregnancy should also understand a positive نتيجة الأجسام المضادة للذئبة (lupus anticoagulant), which is a clotting-risk test despite its confusing name. It is biologically different from anti-Sm and does not diagnose lupus by itself.

What to Expect at a Rheumatology Review

A rheumatology assessment after anti-Sm positivity usually combines a detailed symptom timeline, examination, repeat targeted laboratories, and urine testing. The appointment is not simply a yes-or-no antibody interpretation; it is an assessment of current organ involvement and alternative explanations.

Rheumatology assessment from over shoulder with symptom timeline, joint examination model, and lupus test reports
الشكل 12: A rheumatology visit integrates symptoms, examination, and targeted lupus testing.

Bring laboratory reports rather than screenshots alone, including dates and reference ranges. Mention rashes, fevers, mouth sores, joint stiffness duration, miscarriages, clots, neurologic symptoms, medication exposures, and family history. A normal exam between episodes does not invalidate a useful photograph of a transient rash.

The clinician may request ANA by indirect immunofluorescence, ENA profile, anti-dsDNA, complement, CBC, metabolic panel, urinalysis, urine protein ratio, antiphospholipid antibodies, and selected infection or thyroid tests. Not every person needs every test; focused testing lowers incidental findings.

كانتيستي هو أداة تحليل ديال تحاليل الدم مدعومة بالذكاء الاصطناعي used across 127+ countries to organize multi-laboratory reports before appointments. Readers can also review our دليل المؤشرات الحيوية الذي يتضمن 15,000+ to understand which results belong to kidney, immune, and blood-count domains.

When an Anti-Sm Positive Result Needs Urgent Care

Seek urgent medical assessment for chest pain with breathlessness, coughing blood, new seizure, new confusion, severe headache with neurologic symptoms, rapidly worsening swelling, or visibly bloody urine. These symptoms may reflect serious complications but are not caused by anti-Sm itself.

Urgent lupus symptom assessment with clinical monitor, urine testing materials, and emergency triage environment
الشكل 13: Certain cardiopulmonary, neurologic, and kidney symptoms require urgent evaluation.

A sudden severe headache, weakness on one side, speech difficulty, or seizure needs emergency assessment regardless of whether lupus is confirmed. Similarly, pleuritic chest pain and shortness of breath can result from infection, pulmonary embolism, pericarditis, or other causes that cannot be distinguished safely at home.

Visible blood in urine, markedly reduced urine output, blood pressure of 180/120 mmHg or higher with symptoms, or rapidly increasing leg swelling should prompt same-day medical care. A dipstick alone cannot diagnose nephritis, but it can reveal why waiting is unwise. See our blood-in-urine guide for practical triage context.

For non-urgent situations, schedule primary-care or rheumatology follow-up rather than repeatedly searching isolated test names. The clinical standards behind our interpretation workflows are described in التحقق الطبي, and human assessment remains essential when autoimmune disease is possible.

A Practical Plan After an Anti-Sm Positive Test

The next step after anti-Sm positivity is to verify the assay, screen for organ involvement, and arrange clinician review based on symptoms. There is no evidence-based diet, supplement, or detox that can erase anti-Sm antibodies or substitute for lupus assessment.

Start by obtaining the full report: ANA method and titre, anti-Sm result and units, reference range, and all ENA antibodies. Then collect CBC, creatinine/eGFR, urinalysis, urine protein ratio, C3, C4, and anti-dsDNA if they have not been checked. One well-organized assessment is better than scattered repeated panels.

Do not assume joint pain means lupus or that normal routine blood work excludes it. Symptoms lasting more than 6 weeks, objective swelling, recurrent rash, cytopenias, proteinuria, or low complement justify specialist input. Conversely, an asymptomatic person with reassuring repeat evaluation may need observation rather than medication.

ملكنا المجلس الاستشاري الطبي reviews the clinical guardrails used in Kantesti's educational content. The honest bottom line is reassuringly simple: anti-Sm is a strong clue, not a diagnosis, and the rest of the clinical picture tells you what it means.

الأسئلة الشائعة

واش إيجابية تحليل مضادات سميث كتعني أكيد عندي الذئبة؟

لا. نتيجة إيجابية مؤكدة للأجسام المضادة لـ anti-Sm هي محددة للغاية لمرض الذئبة الحمامية الجهازية، عادة حوالي 95-99%، لكن التشخيص لا يزال يتطلب نتائج سريرية متوافقة واستبعاد البدائل. نظام تصنيف EULAR/ACR لعام 2019 يعطي anti-Sm 6 نقاط، ومع ذلك يتطلب 10 نقاط على الأقل ومعيار سريري واحد بعد معيار الدخول ANA الذي يبلغ 1:80 على الأقل. يجب على طبيب الروماتيزم مراجعة الأعراض، البول، CBC، وظائف الكلى، المكمل، و anti-dsDNA بدلاً من تشخيص الذئبة من anti-Sm وحده.

واش ممكن يكون عندك داء الذئبة مع نتيجة سلبية ديال اختبار الأجسام المضادة لـ Sm؟

وي. فقط حوالي 5-30% من الأشخاص الذين يعانون من الذئبة الحمامية الجهازية الراسخة لديهم أجسام مضادة لـ anti-Sm، لذا فإن النتيجة السلبية لـ anti-Sm لا تستبعد الذئبة. الـ ANA، و anti-dsDNA، ومستويات المكمل، وبروتين البول، وتعداد الدم، والأعراض، ونتائج الفحص هي أكثر إفادة كنقش مجتمع. تختلف الحساسية حسب الأصل العرقي وطريقة الفحص، وهو سبب آخر لعدم حسم نتيجة سلبية واحدة.

شحال كيطلع anti-Sm باش يعتبر طالع بزاف؟

ماكاينش مستوى عالمي لمضاد Sm كيحدد النشاط العالي للمرض أو الذئبة الشديدة. المختبرات ممكن تقدم وحدات اعتباطية، قيم مؤشرات، أنماط تألق، أو ببساطة نتائج إيجابية وسلبية، ومايمكنش تبادل الحدود ديالهم. النتيجة اللي كتفوت الحد ديال المختبر كتكون عندها قيمة سريرية غير ملي كتأكد وكتفسر مع الأعراض والاختبارات المصاحبة. خلافا للبروتين أو الكرياتينين في البول، مستويات مضاد Sm ماشي ديما كيستعملو باش يتبعو اشتداد الذئبة.

أي تحاليل ينبغي أن تتبع اختبار الأجسام المضادة لـ anti-Sm؟

متابعة الإيجابية المضادة لـ Sm تتضمن عادةً ANA عن طريق التألق المناعي غير المباشر، مضاد dsDNA، C3، C4، CBC مع التفريق، الكرياتينين/eGFR، تحليل البول، ونسبة البروتين إلى الكرياتينين في البول. البروتينية المستمرة بمقدار 500 ملغ لكل 24 ساعة أو نسبة 500 ملغ/غرام أو أعلى في حالات الاشتباه بـ SLE تستدعي تقييمًا متخصصًا فوريًا. تعتمد اللوحة الدقيقة على الأعراض، وخطط الحمل، والتعرض للأدوية، والفحص الأصلي.

واش الأجسام المضادة anti-Sm ممكن تولي سالبة؟

الأجسام المضادة لـ Anti-Sm يمكن أن تتغير حسب الفحص وقد تصبح سلبية من حين لآخر، لكنها غالبًا ما تظل قابلة للكشف لسنوات. التغيير من إيجابي إلى سلبي لا يثبت شفاء الذئبة، والنتيجة الإيجابية المستقرة لا تثبت وجود التهاب نشط. يتابع الأطباء عادةً الأعراض، وبروتين البول، والكرياتينين، والمتممات، و CBC، ومضادات الحمض النووي المزدوجة بشكل أوثق من قياسات anti-Sm المتسلسلة. يعتبر تكرار قياس anti-Sm مفيدًا جدًا عندما تكون النتيجة الأولى حدودية أو غير متوقعة سريريًا.

Is anti-Sm the same as lupus anticoagulant?

No. Anti-Sm is an antinuclear antibody associated with systemic lupus erythematosus, while lupus anticoagulant is an antiphospholipid antibody test associated with clotting and pregnancy complications. Lupus anticoagulant can occur with or without lupus, and anti-Sm does not by itself predict a clot. Both tests may appear in an autoimmune work-up, but they answer different clinical questions and require separate interpretation.

احصل على تحليل الدم بالذكاء الاصطناعي اليوم

انضم إلى أكثر من 2 مليون مستخدم عالمي يثقون في Kantesti لتحليل فوري ودقيق لنتائج التحاليل المخبرية. ارفع نتائج تحليل الدم الخاصة بك واحصل على تفسير شامل لـ 15,000+ للـ biomarkers في ثوانٍ.

📚 أبحاث منشورة مُشار إليها

1

Klein, T., Mitchell, S., & Weber, H. (2026). اختبار الدم لفيروس نيباه: دليل الكشف المبكر والتشخيص 2026. Kantesti بحث طبي بالذكاء الاصطناعي.

2

Klein, T., Mitchell, S., & Weber, H. (2026). دليل فصيلة الدم B السالبة، تحليل LDH، وعدّ الخلايا الشبكية. Kantesti بحث طبي بالذكاء الاصطناعي.

📖 مراجع طبية خارجية

3

Aringer M et al. (2019). 2019 معايير التصنيف لمرض الذئبة الحمامية الجهازية من الرابطة الأوروبية لمكافحة الروماتيزم/الكلية الأمريكية لأمراض الروماتيزم. الروماتيزم وأمراض المفاصل.

4

باتري إم وآخرون. (2012). اشتقاق وتحقق من معايير التصنيف ديال Systemic Lupus International Collaborating Clinics لمرض الذئبة الحمراء الجهازية (systemic lupus erythematosus). Arthritis & Rheumatism.

2 مليون+الاختبارات التي تم تحليلها
127+بلدان
75+اللغات

⚕️ إخلاء مسؤولية طبية

إشارات الثقة E-E-A-T

⭐

خبرة

مراجعة سريرية يقودها الأطباء لسير عمل تفسير التحاليل.

📋

خبرة

تركيز طب المختبر على كيفية سلوك الـ biomarkers في السياق السريري.

👤

السلطة

مكتوب من طرف الدكتور Thomas Klein مع مراجعة من طرف الدكتورة Sarah Mitchell والأستاذ الدكتور Hans Weber.

🛡️

الجدارة بالثقة

تفسير قائم على الأدلة مع مسارات متابعة واضحة لتقليل الإنذار.

🏢 شركة كانتيستي المحدودة مسجّل في إنجلترا وويلز · رقم الشركة. 17090423 لندن، المملكة المتحدة · kantesti.net
blank
بواسطة Prof. Dr. Thomas Klein

الدكتور توماس كلاين هو طبيب أمراض دم سريري معتمد من المجلس، ويشغل منصب المدير الطبي التنفيذي في Kantesti AI. يتمتع بخبرة تزيد عن 15 عامًا في طب المختبرات، وله اهتمام قوي بتفسير نتائج تحليل الدم المدعوم بالذكاء الاصطناعي. يعمل على ربط التكنولوجيا الجديدة بالممارسة السريرية اليومية. تشمل مجالات اهتمامه تحليل المؤشرات الحيوية، وأبحاث دعم القرار السريري، وتحسين نطاقات المراجع الخاصة بكل فئة سكانية. بصفته المدير الطبي التنفيذي، يساهم برؤى سريرية في المعايرة الداخلية للمنصة، ويقدم إشرافًا سريريًا على الجودة الطبية للتقارير التعليمية الخاصة بـ Kantesti.

أضف تعليقاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *